Business Wire

Cybin’s EMBARK Program Announces Graduation of Facilitators

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics®”, today announced the graduation of highly-skilled facilitators

More

Wellbeing Announces Definitive Agreement to Divest IRP Health

PURSUANT TO COMPLETION OF DUE DILIGENCE, WELLBEING WILL DIVEST ITS EQUITY STAKE IN IRP VANCOUVER, British Columbia--(BUSINESS WIRE)--$KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FR

More

Oragenics to Participate in the 2022 BioFlorida Annual Conference

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conferenc

More